BackSorrento Therapeutics Overview

Sorrento Therapeutics Total Revenue

Revenue analysis for SRNE.

Quarterly Revenue

$15.03M
↑ 31.1% YoY

As of Jun 2023

Annual Revenue (TTM)

$64.27M
↑ 16.89% YoY

Trailing 12 months ending Jun 2023

Average Revenue (Comparison Companies)

Loading

Total Revenue History

Loading

Total Revenue Comparison

Loading

Annual Revenue Growth Rate (%)

Loading

Annual Revenue Growth (Absolute)

Loading
Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin